somatostatin
Ligand Summary
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.
PubChem: 16129706
ChEMBL: CHEMBL1823872
DrugCentral: 2997
LyCHI: L2NYLN78KPXZ
Target Activities
5 Activities
Items per page:
1 – 5 of 5
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | AGONIST | |||||
Ki | AGONIST | |||||
Ki | AGONIST | |||||
Ki | AGONIST | |||||
Ki | AGONIST | |||||